Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in SPRO — Spero Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in SPRO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,251,586
+$34,969 QoQ
Shares Held
566,329
+8.9% QoQ
Ownership
0.972%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 59 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. SPRO ranks #307 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SPRO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,251,586 566,329
2026-03-31 $1,216,617 519,922
2025-12-31 $1,233,023 529,195
2025-09-30 $991,656 527,477
2025-06-30 $1,481,027 510,699
2025-03-31 $377,905 524,869
2024-12-31 $495,560 481,128
2024-09-30 $644,789 481,187
2024-06-30 $639,842 492,187
2024-03-31 $807,438 469,441
2023-12-31 $606,679 412,707
2023-09-30 $499,375 412,707
2023-06-30 $566,667 390,805
2023-03-31 $489,891 337,856
2022-12-31 $445,101 257,284
2022-09-30 $580,516 290,258
2022-06-30 $215,081 290,258
2022-03-31 $4,099,344 471,189
2021-12-31 $7,319,515 457,184
2021-09-30 $8,190,866 444,914
2021-06-30 $5,776,103 413,761
2021-03-31 $5,352,353 363,611
2020-12-31 $6,944,489 358,148
2020-09-30 $2,225,627 199,429
2020-06-30 $2,661,351 196,700
2020-03-31 $1,254,209 155,224